IVF - INVO Fertility, Inc. Stock Analysis

Stock Taper

SCREENER COMPARE ANY 2 STOCKS

IVF

INVO FERTILITY, INC.

NASDAQ

$1.00

▼ DOWN 2.91% (-0.03)

KEY STATISTICS

Market Cap$1.79 M

52w High$84.40

52w Low$0.90

Dividend Yield—

Frequency—

P/E-0.03

Volume311.83K

Shares Out.1.79M

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Steven Shum

ABOUT

SECTOR

Healthcare

WENT PUBLIC

November 2, 2020

METHOD OF GOING PUBLIC

N/A

FULL TIME EMPLOYEES

PRICE TARGET

Target High$20.00

Target Low$20.00

Target Median$20.00

Target Consensus$20.00

UPCOMING EARNINGS

DateNov 23, 2026

DayMonday

Rev. Est.$2.71M

NOV

MON

SPLIT RECORD

DATE	TYPE	RATIO
2026-03-27	Reverse	1:5
2025-11-28	Reverse	1:8
2025-07-21	Reverse	1:3
2025-03-18	Reverse	1:12
2023-07-28	Reverse	1:20
2020-11-09	Reverse	5:8
2020-05-26	Reverse	1:20
2008-11-13	Forward	5:1

PRICE

$1.00 ▼ DOWN 2.91% (−$0.03)

OVERLAYS

About INVO Fertility, Inc.

https://www.invofertility.com ↗

INVO Fertility, Inc., founded in 2007 in Sarasota, FL, is a revenue-generating fertility company also developing clinical-stage assets in oncology and autoimmune diseases.

INDUSTRY

Medical - Devices

A PRODUCT INVO FERTILITY, INC. IS KNOWN FOR

INVOcell

INVOcell is a proprietary device enabling intravaginal culture for fertilization and early embryo development, offering a more accessible and intimate assisted reproductive technology option through INVO Fertility.